Immunohistochemical and Mutational Analyses of β-catenin, Ki-ras, and p53 in Two Subtypes of Colorectal Mucinous Carcinoma

Clinical Cancer Research

Volumn 9, Issue 15, 2003, Pages 5660-5665

  Ikeda, Satoshi ^a   Shimizu, Yosuke ^a   Fujimori, Masahiko ^a   Ishizaki, Yasuyo ^a   Kurihara, Takeshi ^a   Ojima, Yasutomo ^a   Okajima, Masazumi ^a   Asahara, Toshimasa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PROTEIN P53; WNT PROTEIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CARCINOGENESIS; COLORECTAL CARCINOMA; COLORECTAL MUCINOUS CARCINOMA; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KI RAS GENE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NONMUCINOUS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STAINING; SURVIVAL RATE;

ADENOCARCINOMA, MUCINOUS; AGED; BASE SEQUENCE; BETA CATENIN; CODON; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; ONCOGENE PROTEIN P21(RAS); SURVIVAL ANALYSIS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0344629823     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jass, J. R., and Sobin, L. H. Histological Typing of Intestinal Tumors. Berlin: Springer-Verlag, 1989.
2. Yamamoto, S., Mochizuki, H., Hase, K., Yamamoto, T., Ohkusa, Y., Yokoyama, S., Ushitani, Y., and Tamakuma, S. Assessment of clinicopathologic features of colorectal mucinous adenocarcinoma. Am. J. Surg., 166: 257-261, 1993.
3. Wu, C. S., Tung, S. Y., Chen, P. C., and Kuo, Y. C. Clinicopathological study of colorectal mucinous carcinoma in Taiwan: a multivariate analysis. J. Gastroenterol. Hepatol., 11: 77-81, 1996.
4. Nozoe, T., Anai, H., Nasu, S., and Sugimachi, K. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J. Surg. Oncol., 75: 103-107, 2000.
5. Consorti, F., Lorenzotti, A., Midiri, G., and Di Paola, M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J. Surg. Oncol., 73: 70-74, 2000.
6. Purdie, C. A., and Piris, J. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology, 36: 121-126, 2000.
7. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996,
8. Laurent-Puig, P., Olschwang, S., Delattre, O., Validire, P., Melot, T., Mosseri, V., Salmon, R. J., and Thomas. G. Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma. Int. J. Cancer, 49: 220-223, 1991.
9. Campo, E., de la Calle-Martin, O., Miquel, R., Palacin, A., Romero, M., Fabregat, V., Vives, J., Cardesa, A., and Yague, J. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res., 51: 4436-4442, 1991.
10. Hanski, C., Bornhoeft, G., Shimoda, T., Hanski, M. L., Lane, D. P., Stein, H., and Riecken, E. O. Expression of p53 protein in invasive colorectal carcinomas of different histologic types. Cancer (Phila.), 70: 2772-2777, 1992.
11. Hedrick, L., Cho, K. R., Fearon, E. R., Wu, T. C., Kinzler, K. W., and Vogelstein, B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev., 8: 1174-1183. 1994.
12. Hanski, C., Hofmeier, M., Schmitt-Graff, A., Riede, E., Hanski, M. L., Borchard, F., Sieber, E., Niedobitek, F., Foss, H. D., Stein, H., and Riecken, E. O. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J. Pathol., 182: 385-391. 1997.
13. Ho, S. B., Niehans, G. A., Lyftogt, C., Yan, P. S., Cherwitz, D. L., Gum, E. T., Dahiya, R., and Kim, Y. S. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res., 53: 641-651, 1993.
14. Sobin, L. H., and Wittekind, C. (eds.). UICC TNM Classification of Malignant Tumors. New York: John Wiley & Sons. Inc., 1997.
15. Fujimori, M., Ikeda, S., Shimizu, Y., Okajima, M., and Asahara, T. Accumulation of β-catenin protein and mutations in exon 3 of β-catenin gene in gastrointestinal carcinoid tumor. Cancer Res., 61: 6656-6659, 2001.
16. Shimizu, Y., Ikeda, S., Fujimori, M., Kodama, S., Nakahara, M., Okajima, M., and Asahara, T. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer, 33: 73-81, 2002.
17. Nakahara, M., Yokozaki, H., Yasui, W., Dohi, K., and Tahara, E. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds. Cancer Epidemiol. Biomarkers Prev., 6: 1057-1064, 1997.
18. Kikuchi, A. Modulation of Wnt signaling by Axin and Axil. Cytokine Growth Factor Rev., 10: 255-265, 1999.
19. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., and Kikuchi, A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J., 17: 1371-1384, 1998.
20. Ikeda, S., Kishida, M., Matsuura, Y., Usui, H., and Kikuchi, A. GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with Axin. Oncogene, 19: 537-545, 2000.
21. Tetsu, O., and McCormick, F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.
22. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998.
23. Barbacid, M. ras Genes. Annu. Rev. Biochem., 56: 779-827, 1987.
24. Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res., 49: 4682-4689, 1989.
25. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
26. Soussi, T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann. N. Y. Acad. Sci., 910: 121-139, 2000.